Low free thyroxine concentrations and deficient nocturnal surge of thyroid-stimulating hormone in haemodialysed patients compared with undialysed patients

Nephrology Dialysis Transplantation

Volumn 15, Issue 5, 2000, Pages 668-672

  Yonemura, Katsuhiko ^a   Nakajima, Toshiaki ^a   Suzuki, Takayuki ^a   Ando, Shinichiro ^a   Genma, Rieko ^a   Nakamura, Hirotoshi ^a   Hishida, Akira ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic renal failure; Haemodialysis; Thyroid hormone; Thyroid stimulating hormone

Indexed keywords

LIOTHYRONINE; PROTIRELIN; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; CHEMOLUMINESCENCE; CIRCADIAN RHYTHM; CONTROLLED STUDY; FREE THYROXINE INDEX; HEMODIALYSIS PATIENT; HUMAN; HYPOPHYSIS THYROID SYSTEM; IMMUNOASSAY; LIOTHYRONINE BLOOD LEVEL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

EID: 0034009701     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/15.5.668     Document Type: Article

References (30)

1. 4 syndrome' in subjects on regular hemodialysis and continuous ambulatory peritoneal dialysis. Nephron 1987; 46: 225-230
2. Spector DA, Davis PJ, Helderman JH, Bell B, Utiger RD. Thyroid function and metabolic state in chronic renal failure. Ann Intern Med 1976; 85: 724-730
3. Kaptein EM, Quion-Verde H, Chooljian CJ et al. The thyroid in end-stage renal disease. Medicine 1988; 67: 187-197
4. Goffin E, Oliveira DBG, Raggatt P, Evans DB. Assessment of the thyroid function of patients undergoing regular haemodialysis. Nephron 1993; 65: 568-572
5. Wheatley T, Clark PMS, Clark JDA, Holder R, Raggatt PR, Evans DB. Abnormalities of thyrotrophin (TSH) evening rise and pulsatile release in haemodialysis patients: evidence for hypothalamic pituitary changes in chronic renal failure. Clin Endocrinol 1989; 31: 39-50
6. Hershman JM, Krugman LG, Kopple JD, Reed AW, Azukizawa M, Shinaberger JH. Thyroid function in patients undergoing maintenance hemodialysis: unexplained low serum thyroxine concentration. Metabolism 1978; 27: 755-759
7. Ooi DS, Mahadevan MS, Greenway DC, Gertler SZ. Evaluation of four commercially available assays for free thyroxin. Clin Chem 1988; 34: 2302-2307
8. Bayer MF. Free thyroxine results are affected by albumin concentration and nonthyroidal illness. Clin Chem Acta 1983; 130; 391-396
9. Csako G, Zweig MH, Benson C, Ruddel M. On the albumin-dependence of measurements of free thyroxin. II. Patients with non-thyroidal illness. Clin Chem 1987; 33: 87-92
10. Liewendahl K, Tikanoja S, Helenius T, Valimaki M. Discrepancies between serum free triiodothyronine and free thyroxin as measured by equilibrium dialysis and analog radioimmunoassay in nonthyroidal illnesses. Clin Chem 1984; 30: 760-762
11. Lim VS, Fang VS, Katz AI, Refetoff S. Thyroid dysfunction in chronic renal failure: a study of the pituitary thyroid axis and peripheral turnover kinetics of thyroxine and triiodothyronine. J Clin Invest 1977; 60: 522-534
12. Midgley JEM, Sheehan CP, Christofides ND, Fry JE, Browning D, Mardell R. Concentrations of free thyroxin and albumin in serum in severe nonthyroidal illness: assay artefacts and physiological influences. Clin Chem 1990; 36: 765-771
13. Melmed S, Geola FL, Reed AW, Pekary AE, Park J, Hershman JM. A comparison of methods for assessing thyroid function in nonthyroidal illness. J Clin Endocrinol Metab 1982; 54: 300-306
14. Okabayashi T, Takeda K, Kawada M et al. Free thyroxine concentrations in serum measured by equilibrium dialysis in chronic renal failure. Clin Chem 1996; 42: 1616-1620
15. Czernichow P, Dauzet MC, Broyer M, Rappaport R. Abnormal TSH, PRL and GH response to TSH releasing factor in chronic renal failure. J Clin Endrocrinol Metab 1976; 43: 630-637
16. Ramirez G, Bittle PA, Sanders H, Bercu BB. Hypothalamohypophyseal thyroid and gonadal function before and after erythropoietin therapy in dialysis patients. J Clin Endcrinol Metab 1992; 74: 517-524
17. Ramirez G, O'Neill W Jr, Jubiz W, Bloomer HA. Thyroid dysfunction in uremia: evidence for thyroid and hypophyseal abnormalities. Ann Intern Med 1976; 84: 672-676
18. Duntas L, Wolf CF, Keck FS, Rosenthal J. Thyrotropin-releasing hormone: pharmacokinetic and pharmacodynamic properties in chronic renal failure. Clin Nephrol 1992; 38: 214-218
19. Bartalena L, Pacchiarotti A, Palla R et al. Lack of nocturnal serum thyrotropin (TSH) surge in patients with chronic renal failure undergoing regular maintenance homofiltration: a case of central hypothyroidism. Clin Nephrol 1990; 34: 30-34
20. Mardell R, Gamlen TR. Artifactual reduction in circulating free thyroxine concentration by radioimmunoassay. Lancet 1982; 1: 973-974
21. Larsen PR, Ingar SH. The thyroid gland. In: Wilson JD, Foster DW (eds), Williams Textbook of Endocrinology. WB Saunders: 1992; 357-488
22. Caron PJ, Nieman LK, Rose SR, Nisula BC. Deficient nocturnal surge of thyrotropin in central hypothyroidism. J Clin Endocrinol Metab 1986; 62: 960-964
23. Baumgart P, Walger P, Gemen S, von Eiff M, Raidt H, Rahn KH. Blood pressure elevation during the night in chronic renal failure, hemodialysis and after renal transplantation. Nephron 1991; 57: 293-298
24. Luik AJ, Struijk DG, Gladziwa U et al. Diurnal blood-pressure variations in haemodialysis and CAPD patients. Nephrol Dial Transplant 1994; 9: 1616-1621
25. Portaluppi F, Montanari L, Vergnani L et al. Loss of the nocturnal increase in plasma concentration of atrial natriuretic peptide in hypertensive chronic renal failure. Cardiology 1992; 80: 312-323
26. Biasioli S, Mazzali A, Foroni R et al. Chronobiological variations of prolactin (PRL) in chronic renal failure (CRF). Clin Nephrol 1988; 30: 86-92
27. Tsigos C, Papanicolaou DA, Defensor R, Mitsiadis CS, Kyrou I, Chrousos GP. Dose effects of recombinant human interleukin-6 on pituitary hormone secretion and energy expenditure. Neuroendocrinology 1997; 66: 54-62
28. De Marchi S, Falleti E, Giacomello R et al. Risk factors for vascular disease and arteriovenous fistula dysfunction in hemodialysis patients. J Am Soc Nephrol 1996; 7: 1169-1177
29. Irish AB. Plasminogen activator inhibitor-1 activity in chronic renal disease and dialysis. Metabolism 1997; 46: 36-40
30. Kario K, Matsuo T, Kobayashi H, Matsuo M, Asada R, Koide M. High lipoprotein (a) levels in chronic hemodialysis patients are closely related to the acute phase reaction. Thromb Haemostasis 1995; 74: 1020-1024